Eyal Sobol Selected Research

2,2,3,3-tetramethylcyclopropane carboxamide

1/2007	Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
12/2005	Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eyal Sobol Research Topics

Disease

2	Epilepsy (Aura) 06/2006 - 08/2004
1	Poisoning 06/2015
1	Neural Tube Defects (Exencephaly) 01/2007
1	Pain (Aches) 09/2006
1	Seizures (Absence Seizure) 09/2006
1	Neuralgia (Stump Neuralgia) 12/2005
1	Hyperalgesia 12/2005

Drug/Important Bio-Agent (IBA)

4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2007 - 08/2004
3	Valproic Acid (Depakote)FDA LinkGeneric 06/2006 - 08/2004
2	2,2,3,3-tetramethylcyclopropane carboxamideIBA 01/2007 - 12/2005
1	Synthetic CathinoneIBA 06/2015
1	N- methoxy- 2,2,3,3- tetramethylcyclopropane carboxamideIBA 01/2007
1	Lamotrigine (Lamictal)FDA LinkGeneric 09/2006
1	Formaldehyde (Formol)FDA Link 09/2006
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2005
1	AcidsIBA 12/2005
1	AmidesIBA 12/2005
1	Hypnotics and Sedatives (Sedatives)IBA 12/2005

Therapy/Procedure

1	Therapeutics 09/2006
1	Ligation 12/2005